Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
Part of paid clinical trials in Sacramento, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT06178354
- Status
- Recruiting
Conditions
- Localized Prostate Carcinoma
- Stage I Prostate Cancer AJCC v8
- Stage II Prostate Cancer AJCC v8
- Stage IIIA Prostate Cancer AJCC v8
- Stage IIIB Prostate Cancer AJCC v8
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cryosurgery — PROCEDUREUndergo focal cryotherapy ablation
- High-Intensity Focused Ultrasound Ablation — PROCEDUREUndergo high intensity frequency ultrasound ablation
- Survey Administration — OTHERAncillary studies
Study Details
This clinical trial evaluates the effectiveness of focal ablation with either focal cryotherapy or high intensity frequency ultrasound for the treatment of men with localized prostate cancer. Focal cryotherapy kills tumor cells by freezing them. High intensity frequency ultrasound uses highly focused ultrasound waves to produce heat and destroy tumor cells.
Key Dates
- First listed
- Dec 21, 2023
- Start date
- Nov 9, 2023
- Status verified
- Jun 2026
- Primary completion
- Nov 30, 2028
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment (cryosurgery, high intensity focused ultrasound)Patients undergo focal cryotherapy or high intensity focused ultrasound on study.
Primary Outcome Measure
Pathologic outcome on surveillance prostate biopsy [ Time Frame: At year 1 and 3 ]
Central Contacts
- Office of Clinical Research916-382-6970
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | Marc Dall'Era (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Sacramento, CA
Related Studies
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerEARLY_PHASE1 · Recruiting · Ivan de Kouchkovsky, MD · San Francisco, California
- High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaRecruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- Two-fraction HDR Monotherapy for Localized Prostate CancerRecruiting · University of California, San Francisco · San Francisco, California
- Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationPHASE2 · Recruiting · SWOG Cancer Research Network · Anchorage, Alaska